skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Challenging issues in molecular-targeted therapy

Short Report

(2151) Views  (434) Full article downloads

Authors: Zoheir Ezziane

Published Date March 2009 Volume 2009:5 Pages 239 - 245
DOI: http://dx.doi.org/10.2147/TCRM.S4749

Zoheir Ezziane

Applied Science and Technology, Higher Colleges of Technology, Al Ain, United Arab Emirates

Abstract: There are a variety of anticancer treatments including chemotherapeutic drugs, which are known to induce cell growth arrest and apoptosis through DNA damage and cytoskeleton toxicity. Meanwhile, histone deacetylase (HDAC) inhibitors could apply their antitumor activity through chromatin remodeling and gene expression modulation that affect the cell cycle and survival pathways. This paper proposes an anticancer three-drug compound and discusses several challenging issues in relation to designing multidrug compounds that could possibly lead to molecular-targeted therapies.

Keywords: molecular-targeted therapy, combination therapy, epigenetic therapy, anticancer drug, personalized medicine product








Readers of this article also read:

Management of postoperative nausea and vomiting: focus on palonosetron
Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection
Tenofovir and its potential in the treatment of hepatitis B virus
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
Role of everolimus in the treatment of renal cell carcinoma
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy